- Home
- SWZ vs RPTX Comparison
SWZ vs RPTX Comparison
Compare SWZ & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWZ
- RPTX
- Stock Information
- Founded
- SWZ 1986
- RPTX 2016
- Country
- SWZ United States
- RPTX Canada
- Employees
- SWZ N/A
- RPTX N/A
- Industry
- SWZ Finance Companies
- RPTX Biotechnology: Pharmaceutical Preparations
- Sector
- SWZ Finance
- RPTX Health Care
- Exchange
- SWZ Nasdaq
- RPTX Nasdaq
- Market Cap
- SWZ 79.6M
- RPTX 69.2M
- IPO Year
- SWZ N/A
- RPTX 2020
- Fundamental
- Price
- SWZ $6.15
- RPTX $1.77
- Analyst Decision
- SWZ
- RPTX Strong Buy
- Analyst Count
- SWZ 0
- RPTX 3
- Target Price
- SWZ N/A
- RPTX $4.50
- AVG Volume (30 Days)
- SWZ 14.2K
- RPTX 96.6K
- Earning Date
- SWZ 01-01-0001
- RPTX 11-06-2025
- Dividend Yield
- SWZ 6.59%
- RPTX N/A
- EPS Growth
- SWZ N/A
- RPTX N/A
- EPS
- SWZ N/A
- RPTX N/A
- Revenue
- SWZ N/A
- RPTX $250,000.00
- Revenue This Year
- SWZ N/A
- RPTX N/A
- Revenue Next Year
- SWZ N/A
- RPTX N/A
- P/E Ratio
- SWZ N/A
- RPTX N/A
- Revenue Growth
- SWZ N/A
- RPTX N/A
- 52 Week Low
- SWZ $7.12
- RPTX $0.89
- 52 Week High
- SWZ $8.57
- RPTX $4.07
- Technical
- Relative Strength Index (RSI)
- SWZ 56.09
- RPTX 67.40
- Support Level
- SWZ $6.10
- RPTX $1.66
- Resistance Level
- SWZ $6.17
- RPTX $1.82
- Average True Range (ATR)
- SWZ 0.05
- RPTX 0.06
- MACD
- SWZ 0.01
- RPTX 0.01
- Stochastic Oscillator
- SWZ 84.25
- RPTX 78.85
About SWZ Swiss Helvetia Fund Inc. (The)
Swiss Helvetia Fund Inc is a non-diversified, closed-end investment company. Its investment objective is to seek long-term capital appreciation through investment in equity and equity-linked securities of Swiss companies. The group invests in various sectors such as pharmaceuticals, food and beverage, industrial goods and services, banks, personal and household goods, construction and materials, biotechnology, medical equipment, chemicals, technology, financial services, insurance, Semiconductors, Information Technology, and retail.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.